Terms: = Germ cell tumor AND H3F3B, H3_3A, 3021, ENSG00000132475, P84243, H3_3B, MGC87783, MGC87782, H3F3
18 results:
1. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
Donev K; Sundararajan V; Johnson D; Balan J; Chambers M; Paulson VA; Scherpelz KP; Abdullaev Z; Quezado M; Cimino PJ; Pratt D; Valerio E; Alves de Castro JV; Carraro DM; Torrezan GT; Wolff BM; Kulikowski LD; Costa FD; Aldape K; Ida CM
J Neuropathol Exp Neurol; 2024 Apr; 83(5):357-364. PubMed ID: 38447592
[TBL] [Abstract] [Full Text] [Related]
2. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
Auffret L; Ajlil Y; Tauziède-Espariat A; Kergrohen T; Puiseux C; Riffaud L; Blouin P; Bertozzi AI; Leblond P; Blomgren K; Froelich S; Picca A; Touat M; Sanson M; Beccaria K; Blauwblomme T; Dangouloff-Ros V; Boddaert N; Varlet P; Debily MA; Grill J; Castel D
Acta Neuropathol; 2023 Dec; 147(1):2. PubMed ID: 38066305
[TBL] [Abstract] [Full Text] [Related]
3. Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma.
Rameh V; Vajapeyam S; Ziaei A; Kao P; London WB; Baker SJ; Chiang J; Lucas J; Tinkle CL; Wright KD; Poussaint TY
AJNR Am J Neuroradiol; 2023 Jul; 44(7):833-840. PubMed ID: 37321859
[TBL] [Abstract] [Full Text] [Related]
4. Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma.
Zhang Q; Yang L; Liu YH; Wilkinson JE; Krainer AR
Sci Transl Med; 2023 Apr; 15(691):eadd8280. PubMed ID: 37043556
[TBL] [Abstract] [Full Text] [Related]
5. Update on quality assurance in neuropathology: Summary of the round robin trials on
Pohl S; Dimitrova L; Grassow-Narlik M; Jöhrens K; Acker T; Dohmen H; Herms J; Dorostkar M; Hartmann C; Hasselblatt M; Neumann M; Reifenberger G; Felsberg J; Schüller U; Zoubaa S; Lorenz J; Rothhammer-Hampl T; Mauch-Mücke K; Riemenschneider MJ
Clin Neuropathol; 2023; 42(3):112-121. PubMed ID: 36999511
[TBL] [Abstract] [Full Text] [Related]
6. Co-occurrence of mutations in
Mellid S; Gil E; Letón R; Caleiras E; Honrado E; Richter S; Palacios N; Lahera M; Galofré JC; López-Fernández A; Calatayud M; Herrera-Martínez AD; Galvez MA; Matias-Guiu X; Balbín M; Korpershoek E; Lim ES; Maletta F; Lider S; Fliedner SMJ; Bechmann N; Eisenhofer G; Canu L; Rapizzi E; Bancos I; Robledo M; Cascón A
Front Endocrinol (Lausanne); 2022; 13():1070074. PubMed ID: 36760809
[TBL] [Abstract] [Full Text] [Related]
7. 3D Whole-body skin imaging for automated melanoma detection.
Marchetti MA; Nazir ZH; Nanda JK; Dusza SW; D'Alessandro BM; DeFazio J; Halpern AC; Rotemberg VM; Marghoob AA
J Eur Acad Dermatol Venereol; 2023 May; 37(5):945-950. PubMed ID: 36708077
[TBL] [Abstract] [Full Text] [Related]
8. Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.
Murugesan K; Necchi A; Burn TC; Gjoerup O; Greenstein R; Krook M; López JA; Montesion M; Nimeiri H; Parikh AR; Roychowdhury S; Schwemmers S; Silverman IM; Vogel A
ESMO Open; 2022 Dec; 7(6):100641. PubMed ID: 36462464
[TBL] [Abstract] [Full Text] [Related]
9. Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas.
Wolter M; Felsberg J; Malzkorn B; Kaulich K; Reifenberger G
Acta Neuropathol Commun; 2022 Mar; 10(1):42. PubMed ID: 35361262
[TBL] [Abstract] [Full Text] [Related]
10. The Evolving Molecular Landscape of High-Grade Gliomas.
Pinarbasi E; Pratt D
Cancer J; 2021 Sep-Oct 01; 27(5):337-343. PubMed ID: 34570447
[TBL] [Abstract] [Full Text] [Related]
11. Electronic DNA Analysis of CSF cell-free tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma.
Bruzek AK; Ravi K; Muruganand A; Wadden J; Babila CM; Cantor E; Tunkle L; Wierzbicki K; Stallard S; Dickson RP; Wolfe I; Mody R; Schwartz J; Franson A; Robertson PL; Muraszko KM; Maher CO; Garton HJL; Qin T; Koschmann C
Clin Cancer Res; 2020 Dec; 26(23):6266-6276. PubMed ID: 33087334
[TBL] [Abstract] [Full Text] [Related]
12. Multiple primary tumors: a case report and review of the literature.
Zhao Z; Sun K; Yan T; Wei R; Guo W
BMC Musculoskelet Disord; 2020 Jun; 21(1):394. PubMed ID: 32571290
[TBL] [Abstract] [Full Text] [Related]
13. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Baumhoer D; Amary F; Flanagan AM
Genes Chromosomes Cancer; 2019 Feb; 58(2):88-99. PubMed ID: 30582658
[TBL] [Abstract] [Full Text] [Related]
14. Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.
Shi L; Shi J; Shi X; Li W; Wen H
J Mol Biol; 2018 May; 430(11):1562-1565. PubMed ID: 29689253
[TBL] [Abstract] [Full Text] [Related]
15. Reliability of store and forward teledermatology for skin neoplasms.
Warshaw EM; Gravely AA; Nelson DB
J Am Acad Dermatol; 2015 Mar; 72(3):426-35. PubMed ID: 25599624
[TBL] [Abstract] [Full Text] [Related]
16. Molecular neuro-oncology in clinical practice: a new horizon.
Weller M; Pfister SM; Wick W; Hegi ME; Reifenberger G; Stupp R
Lancet Oncol; 2013 Aug; 14(9):e370-9. PubMed ID: 23896276
[TBL] [Abstract] [Full Text] [Related]
17. Plasma levels of polychlorinated biphenyls and risk of cutaneous malignant melanoma: a preliminary study.
Gallagher RP; Macarthur AC; Lee TK; Weber JP; Leblanc A; Mark Elwood J; Borugian M; Abanto Z; Spinelli JJ
Int J Cancer; 2011 Apr; 128(8):1872-80. PubMed ID: 20533551
[TBL] [Abstract] [Full Text] [Related]
18. Is the sigma2 receptor a histone binding protein?
Colabufo NA; Berardi F; Abate C; Contino M; Niso M; Perrone R
J Med Chem; 2006 Jul; 49(14):4153-8. PubMed ID: 16821775
[TBL] [Abstract] [Full Text] [Related]